Production of interleukin-10 in asthmatic children after Beta-1-3-glucan

Maternal and Child Department of Universidade Federal de Pernambuco, Brazil.
Allergologia et Immunopathologia (Impact Factor: 1.74). 07/2009; 37(4):188-92. DOI: 10.1016/j.aller.2009.02.005
Source: PubMed


Beta-1-3 Glucan is a polysaccharide extracted from Saccharomyces cerevisiae with a possible immunomodulating action that may have a favourable action on asthma symptoms and other allergic diseases. An experimental study carried out using a murine respiratory model detected a decrease in pulmonary tissue eosinophilia, as well as an increase in Interleukin-10 (IL-10) after glucan use.
This open, exploratory study with blind outcome evaluation included asthmatic children between 6 and 12 years of age with mild to moderate persistent asthma and inadequate disease control (rescue medication needed more than twice a week) in spite of inhaled budesonide 400 microg/day. After a four week run-in period, subcutaneous Beta-1-3-glucan injections were given weekly for the first four weeks and then every two weeks for the last four weeks. IL-10 levels, measured by the immunoenzymatic method (ELISA), were compared before and after glucan administration.
Twenty patients (14 male and 6 female) were included. Mean IL-10 levels were 6.4 pg/ml and 11.3 pg/ml before and after glucan, respectively (p = 0.02). There was also a reduction of asthmatic symptoms score at the end of study.
This is the first study which shows that subcutaneous particulate Beta-1-3-glucan increases serum IL-10 levels in asthmatics. The possibility of glucan being able to modulate allergic sensitisation and having a beneficial action in restoring Th2 function should be assessed by means of properly planned controlled clinical trials, as it may represent a new therapeutic strategy.


Available from: José Angelo Rizzo, Mar 18, 2015
  • Source
    • "The effect of ß-glucans on total IgE levels has not been previously reported. Application of ß-glucan (imunoglukan) in a group of asthmatic patients yielded an increased production of anti-allergic tolerogenic cytokine interleukin 10 (Sarinho et al., 2009). We also observed the effect of pleuran on the peripheral blood eosinophilia. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Recurrent respiratory tract infections (RRTIs) present a very important problem in paediatric praxis. As true immunodeficiencies are rare, one of the most important factors assumed to contribute to increased respiratory morbidity is atopy. Several preparations of natural origin have been used for the prevention of RRTIs, and some of the most effective immunomodulators are biologically active polysaccharides – e.g. ß-glucans. In our randomised, double-blind, placebo-controlled study, we investigated the prevalence of atopy in a group of children with RRTIs and the potential anti-allergic effect of pleuran (ß-glucan isolated from Pleurotus ostreatus) on basic laboratory markers of allergic inflammation. We confirmed that atopy may be an important factor contributing to the increased respiratory morbidity in children with RRTIs. The active treatment with pleuran resulted in a significant reduction of peripheral blood eosinophilia and stabilised the levels of total IgE in serum. This was more evident in atopic subjects. Pleuran showed a potential anti-allergic effect. This previously non-described effect could expand the application of this natural immunomodulator also as a complementary adjuvant therapy in allergic patients. Copyright © 2013 John Wiley & Sons, Ltd.
    Phytotherapy Research 03/2014; 28(3):471-474. DOI:10.1002/ptr.5020 · 2.66 Impact Factor
  • Source
    • "(2000) showed that β-glucan alleviated some symptoms of allergic conjunctivitis, Sarinho et al. (2009) showed the effect of β-glucan on elevating IL-10 production and relieving asthma symptoms, and Damiani et al. (2011) showed the combination of colloidal silver and β-glucan on viral rhinitis and upper respiratory symptoms in children. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This randomized, placebo-controlled, double-blind study compared the effects of daily supplementation for 4 week with 250 mg Wellmune WGP® β-1,3/1,6-Glucan (WGP) with placebo 250 mg/day (rice flour) on physical and psychological health attributes of self-described "moderate" ragweed allergy sufferers. Study participants (mean age = 36 ± 9 year; range 18-53 year) were recruited before the beginning of ragweed season (September) in Northeastern Ohio. Serum IgE concentration, allergy symptoms [via self-report, Visual Analog Scale (VAS), and Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ)], psychological well-being [Profile of Mood States (POMS)], and physical function (RAND SF-36 Medical Outcomes Study) were measured immediately prior to and after supplementation with WGP (n = 24) or placebo (n = 24) for 4 weeks. Data were analyzed using repeated measures analyses of variance (ANOVA). Compared with placebo, WGP reduced total allergy symptoms (28%), symptom severity (52%), and symptom rating on the VAS (37%) (P < 0.05), but had no effect on serum IgE levels. As measured by the POMS, WGP increased participants' rating of vigor (10%), but reduced tension (34%), depression (45%), anger (41%), fatigue (38%), and confusion (34%) (P < 0.05). Study participants given WGP reported increased physical health (11%), energy (19%), and emotional well-being (7%) compared with study participants given the placebo (RAND SF-36 Medical Outcomes Study). The WGP group also reported decreased sleep problems (53%), reduced nasal symptoms (59%), eye symptoms (57%), non-nasal symptoms (50%), activities (53%), emotions (57%), and improved quality of life (QOL) (56%), as well as improved global mood state (13%). Supplementation with WGP for 4 weeks improved allergy symptoms, overall physical health, and emotional well-being compared with placebo in self-described "moderate" ragweed allergy sufferers during ragweed allergy season.
    Food Science & Nutrition 01/2013; 1(1):90-101. DOI:10.1002/fsn3.11
  • [Show abstract] [Hide abstract]
    ABSTRACT: In this paper, we report strong anisotropy found in films deposited by co-evaporation of Co and MgF<sub>2</sub> with no magnetic field applied during deposition. M-H loop was measured in perpendicular direction of the sample, deposited without a magnetic field applied during deposition and TEM image of the sample also obtained.
    Magnetics Conference, 2003. INTERMAG 2003. IEEE International; 01/2003
Show more